{"id":1007,"date":"2000-09-01T12:03:00","date_gmt":"2000-09-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2000\/vergleich-von-ptca-mit-medikamentoeser-behandlung-bei-stabiler-angina-pectoris"},"modified":"2000-09-01T12:03:00","modified_gmt":"2000-09-01T10:03:00","slug":"vergleich-von-ptca-mit-medikamentoeser-behandlung-bei-stabiler-angina-pectoris","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2000\/vergleich-von-ptca-mit-medikamentoeser-behandlung-bei-stabiler-angina-pectoris","title":{"rendered":"Vergleich von PTCA mit medikament\u00f6ser Behandlung bei stabiler Angina pectoris"},"content":{"rendered":"<p>Obwohl es sehr viele Publikationen \u00fcber den Vergleich des Effekts der PTCA bei Patienten mit koronarer Herzkrankheit (KHK) mit anderen Therapieformen gibt, sind nur wenige qualitativ befriedigende Studien zum Vergleich von PTCA mit medikament\u00f6ser Therapie bei stabiler Angina pectoris (AP) zu finden. H. C. Bucher et al. planten eine Metaanalyse zum Therapievergleich PTCA versus medikament\u00f6se [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Obwohl es sehr viele Publikationen \u00fcber den Vergleich des Effekts der PTCA bei Patienten mit koronarer Herzkrankheit (KHK) mit anderen Therapieformen gibt, sind nur wenige qualitativ befriedigende Studien zum Vergleich von PTCA mit medikament\u00f6ser Therapie bei stabiler Angina pectoris (AP) zu finden. H. C. Bucher et al. planten eine Metaanalyse zum Therapievergleich PTCA versus medikament\u00f6se [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[495,1046,2533,129,128,131,451,449,455,453,134,85,86,498,456,135,83,84,87,79,2532,443],"class_list":["post-1007","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-angina-pectoris","tag-atorvastatin","tag-avert-studie","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-cholesterinsynthese-hemmer","tag-cse-hemmer","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-kalziumantagonisten","tag-koronarangiografie","tag-koronarangiographie","tag-koronare-herzkrankheit","tag-lipidsenker","tag-nitrate","tag-pci","tag-perkutane-koronarintervention","tag-perkutane-transluminale-koronare-angioplastie","tag-ptca","tag-rita-2-studie","tag-statine"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1007"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1007\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}